scholarly journals Transcriptional response to the host cell environment of a multidrug-resistant Mycobacterium tuberculosis clonal outbreak Beijing strain reveals its pathogenic features

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Pakorn Aiewsakun ◽  
Pinidphon Prombutara ◽  
Tegar Adriansyah Putra Siregar ◽  
Thanida Laopanupong ◽  
Phongthon Kanjanasirirat ◽  
...  

AbstractTuberculosis is a global public health problem with emergence of multidrug-resistant infections. Previous epidemiological studies of tuberculosis in Thailand have identified a clonal outbreak multidrug-resistant strain of Mycobacterium tuberculosis in the Kanchanaburi province, designated “MKR superspreader”, and this particular strain later was found to also spread to other regions. In this study, we elucidated its biology through RNA-Seq analyses and identified a set of genes involved in cholesterol degradation to be up-regulated in the MKR during the macrophage cell infection, but not in the H37Rv reference strain. We also found that the bacterium up-regulated genes associated with the ESX-1 secretion system during its intracellular growth phase, while the H37Rv did not. All results were confirmed by qRT-PCR. Moreover, we showed that compounds previously shown to inhibit the mycobacterial ESX-1 secretion system and cholesterol utilisation, and FDA-approved drugs known to interfere with the host cholesterol transportation were able to decrease the intracellular survival of the MKR when compared to the untreated control, while not that of the H37Rv. Altogether, our findings suggested that such pathways are important for the MKR’s intracellular growth, and potentially could be targets for the discovery of new drugs against this emerging multidrug-resistant strain of M. tuberculosis.

Author(s):  
Irina Alexandrovna Ratnikova ◽  
Amankeldi Kurbanovich Sadanov ◽  
Nina Nicolaevna Gavrilova ◽  
Saltanat Emilkyzy Orazymbet ◽  
Raushan Zhumabekkyzy Kaptagai

The article describes selection of medicinal plants active against multidrug-resistant strain of tuberculosis causative agent. It has been discovered that all tested extracts of medicinal plants in 1:20 dilutions were active regarding multidrug-resistant strain of Mycobacterium tuberculosis T-320 except for hackberry aqueous extract. The most active was alcohol extract of parmelia, which completely suppressed growth of mycobacteria in 1:100 dilution on the 21st day of cultivation.


PLoS ONE ◽  
2014 ◽  
Vol 9 (5) ◽  
pp. e97837 ◽  
Author(s):  
Laura Geffner ◽  
Juan Ignacio Basile ◽  
Noemí Yokobori ◽  
Denise Kviatcovsky ◽  
Carmen Sabio y García ◽  
...  

The Lancet ◽  
1995 ◽  
Vol 345 (8963) ◽  
pp. 1512-1513 ◽  
Author(s):  
A. Theisen ◽  
C. Reichel ◽  
S. Rüsch-Gerdes ◽  
W.H. Haas ◽  
J.K. Rockstroh ◽  
...  

1994 ◽  
Vol 32 (6) ◽  
pp. 1542-1546 ◽  
Author(s):  
B B Plikaytis ◽  
J L Marden ◽  
J T Crawford ◽  
C L Woodley ◽  
W R Butler ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Maxwell A. Stefan ◽  
Glory M. Velazquez ◽  
George A. Garcia

AbstractMultidrug-resistant Mycobacterium tuberculosis (MDR-TB) accounts for 3.7% of new cases of TB annually worldwide and is a major threat to global public health. Due to the prevalence of the MDR-TB and extensively drug resistant tuberculosis (XDR-TB) cases, there is an urgent need for new drugs with novel mechanisms of action. CarD, a global transcription regulator in MTB, binds RNAP and activates transcription by stabilizing the transcription initiation open-promoter complex (RPo). CarD is required for MTB viability and it has highly conserved homologues in many eubacteria. A fluorescence polarization (FP) assay which monitors the association of MTB RNAP, native rRNA promoter DNA and CarD has been developed. Overall, our objective is to identify and characterize small molecule inhibitors which block the CarD/RNAP interaction and to understand the mechanisms by which CarD interacts with the molecules. We expect that the development of a new and improved anti-TB compound with a novel mechanism of action will relieve the burden of resistance. This CarD FP assay is amenable to HTS and is an enabling tool for future novel therapeutic discovery.


2020 ◽  
Vol 21 ◽  
Author(s):  
Andressa Kelly Ferreira e Silva ◽  
Antonielly Campinho dos Reis ◽  
Emanuelly Elanny Andrade Pinheiroc ◽  
Jonas Nascimento de Sousa ◽  
Felipe Araújo de Alcântara Oliveira ◽  
...  

Background: Microbial resistance to antibiotics is a global public health problem, which requires urgent attention. Platonia insignis is a native species from the eastern Brazilian Amazon, used in the treatment of burns and wounds. Objectives: To evaluate the antimicrobial activity of the hydroalcoholic extract of P. insignis (PIHA), the ethyl acetate fraction (PIAE), and its subfraction containing a mixture of biflavonoids (BF). Moreover, the effect of these natural products on the antibiotic activity against S. aureus strains overexpressing efflux pump genes was also evaluated. Methods: Minimal inhibitory concentrations were determined against different species of microorganisms. To evaluate the modulatory effect on the Norfloxacin-resistance, the MIC of this antibiotic was determined in the absence and presence of the natural products at subinhibitory concentrations. Inhibition of the EtBr efflux assays were conducted in the absence or presence of the natural products. Results: PIHA showed a microbicidal effect against S. aureus and C. albicans, while PIAE was bacteriosctatic for S. aureus. PIAE and BF at subinhibitory concentrations were able to reduce the MIC of Norfloxacin acting as modulating agents. BF was able to inhibit the efflux of EtBr efflux in S. aureus strains overexpressing specific efflux pump genes. Conclusion: P. inignisis a source of efflux pump inhibitors, including volkensiflavone and morelloflavone which were able to potentiate the Norfloxacin activity by NorA inhibition, being also able to inhibit QacA/B, TetK and MsrA. Volkensiflavone and morelloflavone could be used as adjuvant in the antibiotic therapy of multidrug resistant S. aureus strains overexpressing efflux pumps.


2019 ◽  
Vol 19 (8) ◽  
pp. 567-578 ◽  
Author(s):  
Marcus Vinicius Nora de Souza ◽  
Thais Cristina Mendonça Nogueira

Nowadays, tuberculosis (TB) is an important global public health problem, being responsible for millions of TB-related deaths worldwide. Due to the increased number of cases and resistance of Mycobacterium tuberculosis to all drugs used for the treatment of this disease, we desperately need new drugs and strategies that could reduce treatment time with fewer side effects, reduced cost and highly active drugs against resistant strains and latent disease. Considering that, 4H-1,3-benzothiazin-4-one is a promising class of antimycobacterial agents in special against TB-resistant strains being the aim of this review the discussion of different aspects of this chemical class such as synthesis, mechanism of action, medicinal chemistry and combination with other drugs.


Sign in / Sign up

Export Citation Format

Share Document